mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.4 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
myricetin |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.4 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.4 |